DD144761A5 - Verfahren zur herstellung von optisch aktiven phenethanolaminen - Google Patents

Verfahren zur herstellung von optisch aktiven phenethanolaminen Download PDF

Info

Publication number
DD144761A5
DD144761A5 DD79214069A DD21406979A DD144761A5 DD 144761 A5 DD144761 A5 DD 144761A5 DD 79214069 A DD79214069 A DD 79214069A DD 21406979 A DD21406979 A DD 21406979A DD 144761 A5 DD144761 A5 DD 144761A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
phenyl
propylamine
solution
hydroxyethyl
Prior art date
Application number
DD79214069A
Other languages
German (de)
English (en)
Inventor
Jack Mills
Klaus K Schmiegel
Walter N Shaw
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD144761A5 publication Critical patent/DD144761A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/06—Preparation of carboxylic acid nitriles from N-formylated amino compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
DD79214069A 1978-07-03 1979-07-03 Verfahren zur herstellung von optisch aktiven phenethanolaminen DD144761A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92167078A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
DD144761A5 true DD144761A5 (de) 1980-11-05

Family

ID=25445792

Family Applications (2)

Application Number Title Priority Date Filing Date
DD79214069A DD144761A5 (de) 1978-07-03 1979-07-03 Verfahren zur herstellung von optisch aktiven phenethanolaminen
DD79214070A DD144762A5 (de) 1978-07-03 1979-07-03 Verfahren zur herstellung von phenethanolaminen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD79214070A DD144762A5 (de) 1978-07-03 1979-07-03 Verfahren zur herstellung von phenethanolaminen

Country Status (31)

Country Link
EP (3) EP0048037A1 (fr)
JP (2) JPS559097A (fr)
KR (1) KR880002310B1 (fr)
AR (4) AR225744A1 (fr)
AT (2) AT367025B (fr)
AU (2) AU523720B2 (fr)
BE (2) BE877393A (fr)
BG (4) BG31646A3 (fr)
CA (2) CA1142954A (fr)
CH (2) CH643529A5 (fr)
CS (4) CS208662B2 (fr)
DD (2) DD144761A5 (fr)
DE (2) DE2964604D1 (fr)
DK (2) DK160936C (fr)
EG (1) EG14238A (fr)
ES (4) ES482155A1 (fr)
FI (2) FI792082A (fr)
FR (3) FR2430410B1 (fr)
GB (3) GB2028799B (fr)
GR (2) GR72940B (fr)
HU (2) HU179172B (fr)
IE (2) IE48769B1 (fr)
IL (2) IL57671A (fr)
LU (2) LU81457A1 (fr)
NZ (2) NZ190861A (fr)
PH (2) PH14522A (fr)
PL (4) PL121297B1 (fr)
PT (2) PT69843A (fr)
RO (4) RO83052B (fr)
SU (4) SU849997A3 (fr)
ZA (2) ZA793297B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061907A1 (fr) * 1981-03-31 1982-10-06 Beecham Group Plc Amines secondaires, leur préparation, compositions pharmaceutiques les contenant et leur utilisation

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0028105B1 (fr) * 1979-10-25 1983-01-19 Beecham Group Plc Amines secondaires, leur préparation et leur utilisation dans des compositions pharmaceutiques
EP0029320B1 (fr) * 1979-11-15 1985-07-10 Beecham Group Plc Ethanolamines secondaires, leur préparation et leur utilisation dans des compositions pharmaceutiques
DE3161165D1 (en) * 1980-05-08 1983-11-17 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
DE3264364D1 (en) * 1981-03-06 1985-08-01 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
EP0070133B1 (fr) * 1981-07-11 1986-05-14 Beecham Group Plc Phényléthanolamines secondaires, procédés pour leur préparation et leur application pharmaceutique
EP0089154A3 (fr) * 1982-03-12 1984-08-08 Beecham Group Plc Dérivés d'éthanolamine, leur fabrication et leur utilisation en compositions pharmaceutiques
CA1219865A (fr) * 1982-05-14 1987-03-31 Leo Alig Derives de phenethanolamine d'aziridine
CA1258454A (fr) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
JPS5980640A (ja) * 1982-09-27 1984-05-10 イーライ・リリー・アンド・カンパニー ２−ヒドロキシ−２−フエニルエチルアミン類の製造方法
PL144053B1 (en) * 1983-01-31 1988-04-30 Lilly Co Eli Method of stimulating growth of domesticated animals,improving effectivness of food utilization ba domesticated animals and improving leanness of domesticated animals and fodder pre-mixture
CA1262729A (fr) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
EP0151513A1 (fr) * 1984-01-12 1985-08-14 Eli Lilly And Company Agents inotropes
GB8505284D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Growth promoters
PT82120B (en) * 1985-03-01 1988-06-16 Beecham Group Plc Process for preparing veterinary formulations containing ethanolamine derivatives
IT1204416B (it) * 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
JP2837408B2 (ja) * 1987-05-30 1998-12-16 鐘紡株式会社 アクリル系繊維の処理方法
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5191112A (en) * 1989-10-17 1993-03-02 Nissan Chemical Industries, Ltd. Process for optical resolution of (±)-2-(3-benzoyl)-phenylpropionic acid
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
KR100251995B1 (ko) * 1991-08-23 2000-06-01 젠센 제임스 유. 칼슘 수용체 활성 분자
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
CN1312116C (zh) 1994-10-21 2007-04-25 Nps药物有限公司 钙受体活性化合物
DE69722934T2 (de) 1996-05-01 2004-05-27 NPS Pharmaceuticals, Inc., Salt Lake City Verbindungen , die auf anorganische ionen-rezeptoren wirken
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL56308C (fr) * 1941-03-15
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1301134A (en) 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
BE788850A (fr) * 1972-09-15 1973-03-15 Hoffmann La Roche Derives d'acide benzoique
IE39247B1 (en) * 1973-05-07 1978-08-30 Allen & Hanburys Ltd Substituted benzamides
US4000192A (en) * 1973-05-07 1976-12-28 Allen & Hanburys Limited Pharmacologically active compounds
NZ190854A (en) * 1978-06-28 1984-10-19 Beecham Group Ltd 2-hydroxy-2-phenyl ethylamine derivatives;pharmaceutical compositions
CA1145766A (fr) * 1978-07-03 1983-05-03 Jack Mills Phenethanolamines ayant des proprietes optiques et methode pour augmenter la contractilite cardiaque

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061907A1 (fr) * 1981-03-31 1982-10-06 Beecham Group Plc Amines secondaires, leur préparation, compositions pharmaceutiques les contenant et leur utilisation

Also Published As

Publication number Publication date
AU4848779A (en) 1980-01-10
FI792081A (fi) 1980-01-04
ATA463579A (de) 1983-04-15
AU4848979A (en) 1980-01-10
IE791228L (en) 1980-01-03
SU1007554A3 (ru) 1983-03-23
NZ190863A (en) 1982-05-25
GB2028799A (en) 1980-03-12
HU179172B (en) 1982-08-28
GB2028799B (en) 1982-09-08
BE877393A (fr) 1980-01-02
AU523721B2 (en) 1982-08-12
ZA793296B (en) 1981-02-25
RO83051B (ro) 1984-02-28
SU957761A3 (ru) 1982-09-07
AT367025B (de) 1982-05-25
BG31645A3 (en) 1982-02-15
SU849997A3 (ru) 1981-07-23
AR229080A1 (es) 1983-06-15
DE2964091D1 (en) 1982-12-30
FR2450806B1 (fr) 1985-07-12
ES490215A0 (es) 1981-04-16
ES490214A0 (es) 1981-04-16
ES482155A1 (es) 1980-08-16
BG31375A3 (en) 1981-12-15
FR2430410A1 (fr) 1980-02-01
RO77732A (fr) 1981-11-24
RO83051A (fr) 1984-02-21
IL57672A (en) 1983-03-31
GB2101582A (en) 1983-01-19
IE48586B1 (en) 1985-03-20
FR2430411B1 (fr) 1983-08-19
PL117551B1 (en) 1981-08-31
ZA793297B (en) 1981-02-25
CH642618A5 (fr) 1984-04-30
CS208663B2 (en) 1981-09-15
ES8104189A1 (es) 1981-04-16
EP0007204A1 (fr) 1980-01-23
CS209815B2 (en) 1981-12-31
EG14238A (en) 1983-12-31
EP0006766A1 (fr) 1980-01-09
KR880002310B1 (ko) 1988-10-22
KR830001187A (ko) 1983-04-29
JPS6254095B2 (fr) 1987-11-13
PH15275A (en) 1982-11-02
AR231434A1 (es) 1984-11-30
DE2964604D1 (en) 1983-03-03
BE877394A (fr) 1980-01-02
RO83052B (ro) 1984-02-28
RO83052A (fr) 1984-02-21
PL121297B1 (en) 1982-04-30
ATA463679A (de) 1981-10-15
PT69843A (en) 1979-07-01
ES8104190A1 (es) 1981-04-16
JPS559097A (en) 1980-01-22
PL117997B1 (en) 1981-09-30
LU81458A1 (fr) 1979-10-30
GR74524B (fr) 1984-06-29
FI792082A (fi) 1980-01-04
IL57671A (en) 1982-11-30
CS208664B2 (en) 1981-09-15
PT69839A (en) 1979-07-01
DD144762A5 (de) 1980-11-05
CA1142954A (fr) 1983-03-15
IE791227L (en) 1980-01-03
EP0006766B1 (fr) 1983-01-26
GB2101582B (en) 1983-06-08
AR225744A1 (es) 1982-04-30
BG31646A3 (en) 1982-02-15
CH643529A5 (fr) 1984-06-15
AU523720B2 (en) 1982-08-12
AT372937B (de) 1983-11-25
LU81457A1 (fr) 1979-10-30
DK160936C (da) 1991-10-21
FR2450806A1 (fr) 1980-10-03
DK268779A (da) 1980-01-04
GB2028802B (en) 1983-03-30
CS208662B2 (en) 1981-09-15
EP0048037A1 (fr) 1982-03-24
DK160936B (da) 1991-05-06
BG31647A3 (en) 1982-02-15
ES482156A1 (es) 1980-08-16
RO77728A (fr) 1981-11-24
AR227165A1 (es) 1982-09-30
IE48769B1 (en) 1985-05-15
GR72940B (fr) 1984-01-16
PL117996B1 (en) 1981-09-30
DK268679A (da) 1980-01-04
FR2430410B1 (fr) 1986-03-21
FR2430411A1 (fr) 1980-02-01
PL216814A1 (fr) 1980-03-24
JPS559096A (en) 1980-01-22
NZ190861A (en) 1981-12-15
IL57671A0 (en) 1979-10-31
IL57672A0 (en) 1979-10-31
HU179171B (en) 1982-08-28
CA1145767A (fr) 1983-05-03
PH14522A (en) 1981-08-26
EP0007204B1 (fr) 1982-11-24
GB2028802A (en) 1980-03-12
PL216811A1 (fr) 1980-08-25
SU965350A3 (ru) 1982-10-07

Similar Documents

Publication Publication Date Title
DD144761A5 (de) Verfahren zur herstellung von optisch aktiven phenethanolaminen
US4391826A (en) Phenethanolamines, compositions containing the same, and method for effecting weight control
EP0400011B1 (fr) Phenylethanolamines
EP0230581B1 (fr) 3-Amino-4,5-dihydroxypipéridines, procédé pour leur préparation et leur utilisation
DE60027700T2 (de) Bicyclische verbindungen und ihre verwendung als integrinrezeptorliganden
DE3522604A1 (de) Neue feste formen von 2-(gamma)thoxy-4-(n-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)-benzoesaeure, diese formen enthaltende arzneimittel und verfahren zu ihrer herstellung
CH621115A5 (fr)
DD145265A5 (de) Verfahren zur herstellung von phenethanolaminen
EP0589488B1 (fr) (-)-Cimaterol sensiblement pure et ses sels d'addition ainsi que son usage comme médicament ou comme promoteur de croissance
DE69935331T2 (de) Verfahren und verbindungen zur behandlung der depression
DE2727047A1 (de) Indol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE2439859A1 (de) Verfahren zur herstellung von 3-(3,4dihydroxy-phenyl)-serin
CH626047A5 (fr)
DE3042482A1 (de) N-benzoyl- (omega) -anilinoalkancarbonsaeuren, -salze und -ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE69819922T2 (de) 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten
EP0133935A2 (fr) Dérivés d'acides p-oxybenzoiques, procédés pour leur préparation et leur utilisation pour la préparation de médicaments ayant une activité hypolipémique
EP0002672B1 (fr) Pyrrolidines substituées, procédé pour leur préparation et médicaments les contenant
EP1246791B1 (fr) Derives d'aminomethyle-phenyle-cyclohexane
DE2656088A1 (de) Neues benzylalkoholderivat und verfahren zu seiner herstellung
EP0298350A2 (fr) 6-Hydroxy méthyl-3-Amino-4,5-dihydroxy pipéridines chirales, leurs intermédiaires, leurs procédés de préparation et leur utilisation
DD300542A5 (de) Chemische verbindungen
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon
DD144764A5 (de) Verfahren zur herstellung von r-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylaminen
DE2535599A1 (de) Substituierte zimtsaeureamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende zubereitungen
DE2304414C3 (de) 1-[3-(trifluormethyl)phenyl]-2-[(cyanoalkyl)amino]-propane, verfahren zu deren herstellung und diese enthaltende arzneimittel